Since future research should hope to reduce immunosuppressive mechanisms to generate more beneficial treatment options, this review aimed to discuss new therapeutic strategies targeting protein kinases that are simultaneously capable of increasing anti-tumor immunity in the context of brain tumors. The gene discussed is WEE1; the disease is neoplasm.